On 19 March 2020 President Trump called hydroxychloroquine a 'game-changer' for COVID-19 at a White House press briefing. The FDA granted an Emergency Use Authorization on 28 March 2020. Off-label prescribing spiked and Mehmet Oz promoted the drug on television. Two high-profile observational studies — in The Lancet (22 May 2020) and NEJM (1 May 2020) — appeared to show harm from HCQ; both were retracted on 4-5 June 2020 after the Surgisphere database underlying them was found to be fictitious (Sapan Desai, CEO). The FDA revoked the EUA on 15 June 2020. Large randomised trials — RECOVERY and WHO Solidarity — subsequently confirmed no meaningful benefit. The conspiracy framing is that HCQ was suppressed for political or commercial reasons; the reality is more complex: early fraudulent data damaged the evidentiary base, then rigorous trials ruled out benefit.